Menu
Get in Touch
info@emkomnipharma.com

A unit of Sri Rama Associates

Sacomni-100 - Angle 1
Angle 1 of 3

Schedule H Prescription Drug - Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.

Blood Pressure Management

Sacomni-100

Composition

49 mg Sacubitril and 51 mg Valsartan as sodium salt complex, along with approved excipients

Dosage Strength

49 mg & 51 mg

Medicine Type

Tablet

Pack Size

10 X 14 Tablets

Storage Instructions

Sacomni 100 Sacubitril and Valsartan Tablets should be stored in a cool, dry and dark place at a temperature below 25°C.

Caution

Keep out of reach of children. Consult your physician if you experience any adverse effects.

Product Information

Sacomni 100 by EMK Omni Pharma is a prescription-based Sacubitril and Valsartan Tablets formulation used for doctor-supervised heart failure management, cardiac function support and cardiovascular health care. Each film-coated tablet contains Sacubitril 49 mg and Valsartan 51 mg as sodium salt complex. Sacomni 100 is commonly prescribed by healthcare professionals for patients who require support in managing heart failure, cardiac workload, blood pressure control and long-term cardiovascular health. Sacomni 100 Sacubitril 49 mg and Valsartan 51 mg Tablets by EMK Omni Pharma are designed for physician-guided cardiac care where heart failure support, vascular health, blood pressure management and cardiovascular risk control are required. This medicine should be used only as advised by a registered medical practitioner. Sacomni 100 may be prescribed by doctors for patients who require support in managing heart failure, cardiac strain, blood pressure concerns and cardiovascular health risks. It may be used as part of a physician-guided heart care plan where cardiac function support, vascular balance, blood pressure control and long-term cardiovascular management are required. Sacomni 100 by EMK Omni Pharma is suitable for doctor-supervised treatment where heart failure management, cardiac health support and blood pressure control are needed. Patients should not self-medicate, change the dosage, stop the medicine or combine it with other heart medicines without consulting their doctor. As mentioned on the product label, Valsartan should be discontinued as soon as pregnancy is detected, and patients must consult their physician immediately in such cases.

Medical Disclaimer

This product information is intended for general awareness only and should not be considered medical advice. Please consult a registered medical practitioner before using any prescription medicine.